Experiment 473284
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IP |
| Organism | Empty organism |
| Citation | FAVRE,G:. (1992). INCORPORATION OF LOW DENSITY LIPOPROTEIN INTO CANCER CELLS. APPLICATION OF DERIVATIVES OF ELLIPTICINE.. 186(1/2) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE DRUG-LDL COMPLEX EXPRESSED SIMILAR METABOLIC ACTIVITY, IN VITRO AND IN VIVO, THAN NATIVE LDL. INITIAL EXPERIMENTS WITH MELANOMA B16 TUMOR-BEARING MICE SUGGEST THAT LDL MAY BE POTENTIAL DRUG CARRIER IN THE TREATMENT OF MALIGNANT DISEASES. THE KNOWLEDGE OF THE MOLECULAR MECHANISM OF THE EXPRESSION OF THE LDL RECEPTOR IN TUMOR CELLS AND THE ABILITY TO DOWNREGULATE THE LDL RECEPTOR IN THE NORMAL TISSUES, WILL DEFINE THE APPLICATION FIELD OF THIS TARGETTING APPROACH. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | MOUSE |
| Dose expression | DOSE |